These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Survey of Intravitreal Injection Techniques and Treatment Protocols Among Members of the Turkish Ophthalmological Association. Önder Tokuç E; Karabaş VL; Şermet F Turk J Ophthalmol; 2021 Dec; 51(6):373-380. PubMed ID: 34963265 [TBL] [Abstract][Full Text] [Related]
6. [Management of wet AMD in France in 2015]. Zerbib J; Bourhis A; Cornut PL; De Bats F; Grenet T; Gualino V; Halfon J; Massé H; Srour M; Streho M; Tick S; Wolff B; San Nicolas N J Fr Ophtalmol; 2017 Nov; 40(9):723-730. PubMed ID: 29055730 [TBL] [Abstract][Full Text] [Related]
7. All India Ophthalmological Society members' survey: Practice pattern of intravitreal anti-vascular endothelial growth factor injection. Sundar D; Das T; Chhablani J; Kumar A; Sharma N Indian J Ophthalmol; 2020 Jun; 68(6):1095-1098. PubMed ID: 32461437 [TBL] [Abstract][Full Text] [Related]
8. National survey of the ophthalmic use of anti-vascular endothelial growth factor drugs in Israel. Waisbourd M; Goldstein M; Loewenstein A Isr Med Assoc J; 2011 Mar; 13(3):141-6. PubMed ID: 21608333 [TBL] [Abstract][Full Text] [Related]
11. Incidence of endophthalmitis after intravitreal injection of an anti-VEGF agent with or without topical antibiotics. Morioka M; Takamura Y; Nagai K; Yoshida S; Mori J; Takeuchi M; Sawada T; Sone K; Fukuyama H; Kusuhara S; Yasukawa T; Murakami T; Tabuchi H; Nagasato D; Hirano T; Ueda T; Jujo T; Sasajima H; Mitamura Y; Ishikawa K; Inatani M Sci Rep; 2020 Dec; 10(1):22122. PubMed ID: 33335269 [TBL] [Abstract][Full Text] [Related]
12. Asia-Pacific Technology and Trend Survey 2016-2017. Chhablani J; Shaikh A; Goud A; Kawasaki R; Kwon OW; Chang A; Lam D; Das T Asia Pac J Ophthalmol (Phila); 2019; 8(1):43-54. PubMed ID: 30188025 [TBL] [Abstract][Full Text] [Related]
13. Survey: technique of performing intravitreal injection among members of the Brazilian Retina and Vitreous Society (SBRV). Shiroma HF; Farah ME; Takahashi WY; Gomes AM; Goldbaum M; Rodrigues EB Arq Bras Oftalmol; 2015; 78(1):32-5. PubMed ID: 25714535 [TBL] [Abstract][Full Text] [Related]
14. Survey of intravitreal injection techniques among retina specialists in Israel. Segal O; Segal-Trivitz Y; Nemet AY; Geffen N; Nesher R; Mimouni M Clin Ophthalmol; 2016; 10():1111-6. PubMed ID: 27366050 [TBL] [Abstract][Full Text] [Related]
15. Usability of the Ranibizumab 0.5 mg Prefilled Syringe: Human Factors Studies to Evaluate Critical Task Completion by Healthcare Professionals. Antoszyk AN; Baker C; Calzada J; Cummings H; So J; Quezada-Ruiz C; Haskova Z PDA J Pharm Sci Technol; 2018; 72(4):411-419. PubMed ID: 29853609 [TBL] [Abstract][Full Text] [Related]
16. A survey of UK practice patterns in the delivery of intravitreal injections. Samia-Aly E; Cassels-Brown A; Morris DS; Stancliffe R; Somner JE Ophthalmic Physiol Opt; 2015 Jul; 35(4):450-4. PubMed ID: 26094833 [TBL] [Abstract][Full Text] [Related]
17. [French practice patterns in the management of diabetic macular edema]. Qu-Knafo L; Fajnkuchen F; Sarda V; Nghiem-Buffet S; Chaine G; Giocanti-Auregan A J Fr Ophtalmol; 2016 Jun; 39(6):521-6. PubMed ID: 27318630 [TBL] [Abstract][Full Text] [Related]
18. Predictors of Endophthalmitis after Intravitreal Injection: A Multivariable Analysis Based on Injection Protocol and Povidone Iodine Strength. Stem MS; Rao P; Lee IJ; Woodward MA; Faia LJ; Wolfe JD; Capone A; Covert D; Dass AB; Drenser KA; Garretson BR; Hassan TS; Margherio A; Oh KT; Raephaelian PV; Randhawa S; Sneed S; Trese MT; Yedavally S; Williams GA; Ruby AJ Ophthalmol Retina; 2019 Jan; 3(1):3-7. PubMed ID: 30929813 [TBL] [Abstract][Full Text] [Related]
19. Risk for eye splash injury during administration of intraocular injections: a study of retina specialists and fellows. Bourla DH; Wirthlin RS; Bourla N; Gupta A; Stanescu-Segall D; Schwartz SD; Axer-Siegel R Retina; 2007 Jun; 27(5):609-12. PubMed ID: 17558324 [TBL] [Abstract][Full Text] [Related]
20. Effect of Regulatory Requirement for Patient-Specific Prescriptions for Off-Label Medications on the Use of Intravitreal Bevacizumab. Holfinger S; Miller AG; Rao LJ; Rowland DY; Hornik JH; Miller DG JAMA Ophthalmol; 2016 Jan; 134(1):45-8. PubMed ID: 26540671 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]